Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) EBITDA: 2010-2012

Historic EBITDA for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to -$1.9 million.

  • Sonoma Pharmaceuticals' EBITDA rose 26.80% to -$1.9 million in Q4 2012 from the same period last year, while for Dec 2012 it was -$4.7 million, marking a year-over-year increase of 36.99%. This contributed to the annual value of -$7.5 million for FY2012, which is 4.83% up from last year.
  • According to the latest figures from Q4 2012, Sonoma Pharmaceuticals' EBITDA is -$1.9 million, which was down 37.71% from -$1.4 million recorded in Q3 2012.
  • In the past 5 years, Sonoma Pharmaceuticals' EBITDA registered a high of $325,000 during Q2 2012, and its lowest value of -$2.6 million during Q4 2011.
  • Its 3-year average for EBITDA is -$1.7 million, with a median of -$1.7 million in 2012.
  • The largest annual percentage gain for Sonoma Pharmaceuticals' EBITDA in the last 5 years was 115.17% (2012), contrasted with its biggest fall of 38.20% (2012).
  • Sonoma Pharmaceuticals' EBITDA (Quarterly) stood at -$2.2 million in 2010, then decreased by 17.07% to -$2.6 million in 2011, then climbed by 26.80% to -$1.9 million in 2012.
  • Its EBITDA was -$1.9 million in Q4 2012, compared to -$1.4 million in Q3 2012 and $325,000 in Q2 2012.